HER2-PositiveRecurrent or Metastatic Breast Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HER2-PositiveRecurrent or Metastatic Breast Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 3

NCT06057610

A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Canc…

To evaluate the efficacy and safety of SHR-A1811 with or without pertuzumab versus trastuzumab, pertuzumab and docetaxel in HER2-Positive Recurrent or Metastati…

China868 participantsStarted 2023-10-16

Treatment: SHR-A1811 Injection, SHR-A1811 Injection ； Pertuzumab Injection